Laser Therapy

John Nasr
Jason Baaklini

Electrotherapy
By: Dr. Lisa Freih

1
Laser Therapy

Definition:

Laser therapy uses a process called

photobiomodulation. Photons enter the
tissue and interact with the
mitochondria. This interaction triggers a
biological cascade of events that leads
to an increase in cellular metabolism
and a decrease in both pain and
inflammation.

2
Laser Therapy

Indications:

 Soft tissue and sports injuries such as muscle strains and

ligament sprains.
 Repetitive stress injuries such as tendinitis or bursitis.
 Arthritic conditions such as osteoarthritis.
 Tissue repair and wound healing like burns.
 Pain
 Inflammation

3
Laser Therapy

Contraindications:

 Growth plates in children.

 Pregnant patients over the abdominal, low back and pelvic area.
 Around glandular tissue (such as thyroid, testes, ovaries).
 Over pacemakers.
 Patients taking photosensitive medications (such as steroids or antibiotics)
 Malignancy
 Hemorrhage
4
Laser Therapy

Mode of Action:

 The molecular and cellular mechanisms of

laser therapy suggest that photons are
absorbed by the mitochondria. They then
stimulate more ATP production, which
then activates transcription factors, to
induce many gene transcript products
responsible for the beneficial effects of
this therapy.
5
Laser Therapy

Parameters:

 Type of beam: continuous or pulsed

 Frequency: between 2.5Hz to 20,000 Hz
 Spot size: 1 to 3.9mm2
 Distance from skin: 0cm to 10 cm
 Power: 0.2uW to 13W
 Number of treatments : 1 to 36
 Frequency of treatment: 2 to 7 days per week
 Time of treatment: 20s to 30 min 6

 Size of wound: 0.39 to 16cm2

Laser Therapy

Article 1:Low-level Laser Therapy Benefits for

Nonpharmacological Pain Control in Chronic Pain
and Osteoarthritis

 The molecular and cellular mechanisms of LLLT suggest that

photons are absorbed by the mitochondria. They stimulate
more ATP production and low levels of ROS, which then
activates transcription factors, such as NF-κB, to induce many
gene transcript products responsible for the beneficial effects
of LLLT.
7
Laser Therapy

 Based on current research, the utilization of LLLT for pain

management and osteoarthritic conditions may be a
complementary strategy used in clinical practice to
provide symptom management for patients suffering from
osteoarthritis and chronic pain

8
Laser Therapy

Article 2:Effectiveness of low-level laser therapy in patients with knee

osteoarthritis: a systematic review and meta-analysis.

 To investigate the efficacy of low-level laser therapy treatment of knee osteoarthritis

by a systematic literature search with meta-analyses on selected sOf 612 studies, nine
RCTs met the criteria for inclusion. Based on seven studies, the SMD in visual analogue
scale pain score right after therapy (within 2 weeks after the therapy) was not
significantly different between LLLT and control (SMD = -0.28 [95% CI = -0.66, 0.10],
I(2) = 66%). No significant difference was identified in studies conforming to the World
Association of Laser Therapy recommendations or on the basis of OA severity. There
was no significant difference in the delayed response after 12 weeks end of therapy)
between LLLT and control in VAS pain. Similarly, there was no evidence of LLLT
effectiveness based on Western Ontario and McMaster Universities Arthritis Index pain,
stiffness or function outcomes.

9
Laser Therapy

Specific details about Infrared laser device:

 Four wavelength 635nm, 810nm, 980nm and 1064nm in one laser with
maximum power up to 26watt
 Android os smart laser
 Hd color touch screen
 Thermal camera
 Repetition rate: 0,2Hz-20Hz
 Voltage: 110/220 VAC, 5A, 50/60 Hz
 Dimensions: 240h 130w 225l mm
 Weight: 5kg

10
 References

 Huang, Z., et al. "Effectiveness of low-level laser therapy in patients with

knee osteoarthritis: a systematic review and meta-analysis." Osteoarthritis
and cartilage 23.9 (2015): 1437-1444.
 Dima, Robert, et al. "Review of literature on low-level laser therapy benefits
for nonpharmacological pain control in chronic pain and osteoarthritis." trials
5 (2017): 6.

11
12